Ireland-Based Felixvet Plans Briarcliff, Missouri, North American Headquarters
07/14/2023
The new office will serve as the center to support commercial and regulatory operations throughout the U.S. and Canada.
"We are confident that Felixvet is poised to become one of the leading companion animal generic drug companies globally," said Vince Palasota, president of North America at Felix. "With our extensive pipeline, quick response capabilities and deep understanding of ANADA and brand competition strategies, we believe the veterinarian and marketing partners will recognize the significant value-added benefits we bring to the table."
Felix develops bio-equivalent generic pharmaceutical products for companion animals upon patent expiry. The company’s initial focus is to market and distribute these products in the U.S., upon approval by the Food and Drug Administration.
“We are proud to welcome Felixvet, a business committed to advancing animal health through high-quality pharmaceuticals, to the Kansas City region,” noted Kimberly Young, president of the KC Animal Health Corridor. “Here, Felix will enjoy proximity to many of their industry clients who call the KC Animal Health Corridor home, as well as abundant access to distribution resources and a robust animal health industry network."
Project Announcements
Dollar Tree Plans Marietta, Oklahoma, Distribution Operations
04/30/2025
Hitachi Energy Expands Bland, Virginia, Production Operations
04/28/2025
Amgen Expands New Albany, Ohio, Manufacturing Operations
04/28/2025
United Kingdom-Based Balmoral Tanks Plans Mentor, Ohio, Operations
04/28/2025
E & E Hardwoods Expands Bell County, Kentucky, Saw Mill Operations
04/27/2025
Aegis Sortation Expands Louisville, Kentucky, Operations
04/26/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
The Location Economics of Advanced Nuclear
Q1 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Forging Solid Foundations
Q1 2025